Effective February 8, 2015, Lucie Letellier tendered her resignation as CTT Pharmaceutical Holdings, Inc.'s Chief Financial Officer. There was no disagreement between the company and Ms. Letellier regarding the company's operations or financial reporting obligations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 USD | +33.78% | 0.00% | +42.86% |
2020 | CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech | CI |
2020 | CTT Pharmaceutical Holdings, Inc. Announces Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
+42.86% | 2.01M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CTTH Stock
- News CTT Pharmaceutical Holdings, Inc.
- CTT Pharmaceutical Holdings, Inc. Announces Resignation of Lucie Letellier as Chief Financial Officer